Lu Yang, Arup Bhattacharya, Yun Li, Darrell Peterson, Yuesheng Zhang. "A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer." Scientific Reports, 2026. doi:10.1038/s41598-026-47444-3